Flexion Therapeutics Enrolls First Patient in Pharmacokinetic Study of Zilretta™ for Osteoarthritis of the Knee
December 01, 2015 at 16:05 PM EST
Flexion Therapeutics, Inc. (Nasdaq: FLXN) announced today that it has enrolled its first patient in a pharmacokinetic (PK) study of ...